Browse studies
Find your next paid study
15 recruiting studies matching your filters
Phase 1
Pharmacodynamically Monitored Linvoseltamab Dosing De-Escalation in Relapsed Multiple Myeloma
This phase I/II trial evaluates the safety and feasibility of early, response-based dose reduction of linvoseltamab in the treatment of patients multiple myelo…
Recurrent Multiple MyelomaRefractory Multiple Myeloma
Estimated
~$10 – $6,250
Fred Hutchinson Cancer CenterNCT07181941
Phase 1
A Phase 1b Clinical Trial of CRISPR Delivered Anti-BCMA Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Multiple Myeloma
This phase Ib trial tests the safety, side effects and best dose of clustered regularly interspaced short palindromic repeats (CRISPR) delivered anti-B-cell ma…
Multiple MyelomaRecurrent Multiple MyelomaRefractory Multiple Myeloma
Estimated
~$10 – $7,500
Thomas Martin, MDNCT07340853
Observational
Prehabilitation in Patients With Multiple Myeloma Receiving CAR-T Therapy
This clinical trial evaluates whether prehabilitation with aerobic and resistance exercise improves physical fitness and quality of life outcomes in older pati…
Recurrent Multiple MyelomaRefractory Multiple Myeloma
Estimated
~$10 – $6,250
Mayo ClinicNCT07045727